146 related articles for article (PubMed ID: 37619884)
1. Perioperative and oncologic outcomes of pulmonary resection for synchronous oligometastatic non-small cell lung cancer: Evidence for surgery in advanced disease.
Deboever N; Mitchell KG; Farooqi A; Ludmir EB; Hofstetter WL; Mehran RJ; Rajaram R; Rice DC; Sepesi B; Swisher SG; Vaporciyan AA; Walsh GL; Heymach JV; Gomez DR; Gandhi SJ; Antonoff MB
J Thorac Cardiovasc Surg; 2024 Jun; 167(6):1929-1935.e2. PubMed ID: 37619884
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary resection is associated with long-term survival and should remain a therapeutic option in oligometastatic lung cancer.
Mitchell KG; Farooqi A; Ludmir EB; Corsini EM; Sepesi B; Gomez DR; Antonoff MB;
J Thorac Cardiovasc Surg; 2021 Apr; 161(4):1497-1504.e2. PubMed ID: 32331820
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer.
Fleckenstein J; Petroff A; Schäfers HJ; Wehler T; Schöpe J; Rübe C
BMC Cancer; 2016 Jun; 16():348. PubMed ID: 27255302
[TBL] [Abstract][Full Text] [Related]
4. Surgical treatment of primary lung cancer with synchronous brain metastases.
Billing PS; Miller DL; Allen MS; Deschamps C; Trastek VF; Pairolero PC
J Thorac Cardiovasc Surg; 2001 Sep; 122(3):548-53. PubMed ID: 11547308
[TBL] [Abstract][Full Text] [Related]
5. Surgery for oligometastatic non-small cell lung cancer: long-term results from a single center experience.
Congedo MT; Cesario A; Lococo F; De Waure C; Apolone G; Meacci E; Cavuto S; Granone P
J Thorac Cardiovasc Surg; 2012 Aug; 144(2):444-52. PubMed ID: 22713303
[TBL] [Abstract][Full Text] [Related]
6. Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): patient outcomes and prognostic factors.
Griffioen GH; Toguri D; Dahele M; Warner A; de Haan PF; Rodrigues GB; Slotman BJ; Yaremko BP; Senan S; Palma DA
Lung Cancer; 2013 Oct; 82(1):95-102. PubMed ID: 23973202
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non-Small Cell Lung Cancer.
Uhlig J; Case MD; Blasberg JD; Boffa DJ; Chiang A; Gettinger SN; Kim HS
JAMA Netw Open; 2019 Aug; 2(8):e199702. PubMed ID: 31433481
[TBL] [Abstract][Full Text] [Related]
8. Improved Overall Survival With Comprehensive Local Consolidative Therapy in Synchronous Oligometastatic Non-Small-Cell Lung Cancer.
Mitchell KG; Farooqi A; Ludmir EB; Corsini EM; Zhang J; Sepesi B; Vaporciyan AA; Swisher SG; Heymach JV; Zhang J; Gomez DR; Antonoff MB
Clin Lung Cancer; 2020 Jan; 21(1):37-46.e7. PubMed ID: 31447303
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of a Highly Selective Surgical Approach to Oligometastatic Lung Cancer.
Johnson KK; Rosen JE; Salazar MC; Boffa DJ
Ann Thorac Surg; 2016 Oct; 102(4):1166-71. PubMed ID: 27344278
[TBL] [Abstract][Full Text] [Related]
10. Survival of patients treated surgically for synchronous single-organ metastatic NSCLC and advanced pathologic TN stage.
Collaud S; Stahel R; Inci I; Hillinger S; Schneiter D; Kestenholz P; Weder W
Lung Cancer; 2012 Dec; 78(3):234-8. PubMed ID: 23040415
[TBL] [Abstract][Full Text] [Related]
11. Survival outcomes for oligometastasis in resected non-small cell lung cancer.
Shimada Y; Saji H; Kakihana M; Kajiwara N; Ohira T; Ikeda N
Asian Cardiovasc Thorac Ann; 2015 Oct; 23(8):937-44. PubMed ID: 26207006
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic Ablative Body Radiotherapy (SABR) in Pulmonary Oligometastatic/Oligorecurrent Non-small Cell Lung Cancer Patients: A New Therapeutic Approach.
Agolli L; Valeriani M; Nicosia L; Bracci S; De Sanctis V; Minniti G; Enrici RM; Osti MF
Anticancer Res; 2015 Nov; 35(11):6239-45. PubMed ID: 26504057
[TBL] [Abstract][Full Text] [Related]
13. Surgery of primary lung cancer with oligometastatic m1b synchronous single brain metastasis: analysis of 37 cases.
Cheufou DH; Welter S; Chalvatzoulis E; Christof D; Theegarten D; Stamatis G
Thorac Cardiovasc Surg; 2014 Oct; 62(7):612-5. PubMed ID: 25136943
[TBL] [Abstract][Full Text] [Related]
14. Resection of the Primary Tumor and Survival in Patients with Single-Site Synchronous Oligometastatic Non-Small Cell Lung Cancer: Propensity-Matched Analysis of the National Cancer Database.
Rodriguez-Quintero JH; Jindani R; Kamel MK; Zhu R; Vimolratana M; Chudgar NP; Stiles BM
J Am Coll Surg; 2024 Jun; 238(6):1122-1136. PubMed ID: 38334285
[TBL] [Abstract][Full Text] [Related]
15. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
[TBL] [Abstract][Full Text] [Related]
16. Multimodal therapy for synchronous bone oligometastatic NSCLC: The role of surgery.
Congedo MT; Nachira D; Bertolaccini L; Chiappetta M; Zanfrini E; Meacci E; Vita ML; Lococo F; D'Argento E; Spaggiari L; Margaritora S
J Surg Oncol; 2022 Mar; 125(4):782-789. PubMed ID: 34918785
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary Resection for Synchronous M1b-cStage IV Non-Small Cell Lung Cancer Patients.
Yamaguchi M; Edagawa M; Suzuki Y; Toyozawa R; Hirai F; Nosaki K; Seto T; Takenoyama M; Ichinose Y
Ann Thorac Surg; 2017 May; 103(5):1594-1599. PubMed ID: 27863731
[TBL] [Abstract][Full Text] [Related]
18. Surgical Outcomes after Pulmonary Resection for Non-Small Cell Lung Cancer with Localized Pleural Seeding First Detected during Surgery.
Yun JK; Kim MA; Choi CM; Choi SH; Kim YH; Kim DK; Park SI; Kim HR
Thorac Cardiovasc Surg; 2018 Mar; 66(2):142-149. PubMed ID: 26669768
[TBL] [Abstract][Full Text] [Related]
19. Locoregional Control, Overall Survival, and Disease-Free Survival in Stage IIIA (N2) Non-Small-Cell Lung Cancer: Analysis of Resected and Unresected Patients.
Rajaram R; Correa AM; Xu T; Nguyen QN; Antonoff MB; Rice D; Mehran R; Roth J; Walsh G; Swisher S; Hofstetter WL; Vaporciyan A; Cascone T; Tsao AS; Papadimitrakopoulou VA; Gandhi S; Liao Z; Sepesi B
Clin Lung Cancer; 2020 Jul; 21(4):e294-e301. PubMed ID: 32089476
[TBL] [Abstract][Full Text] [Related]
20. [Oligometastatic non-small cell lung cancer--surgical options and therapy strategies].
Schreiner W; Semrau S; Fietkau R; Sirbu H
Zentralbl Chir; 2014 Jun; 139(3):335-41. PubMed ID: 24810892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
